Eli Lilly & Co
LLY· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $5.59B | $5.82B | $5.40B | $4.98B |
| Net Income | -$259.90M | $1.01B | $747.70M | $600.80M |
| EPS Diluted | -$0.25 |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $0.95 |
| $0.71 |
| $0.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.